摘要 |
An aminomethylpyridyloxymethyl/benzisoxazole substituted azabicyclic compound of formula I, pharmaceutical composition comprising same, and a method of treating one or more CNS or other disorders, including concurrent treatment of disorders such as schizophrenia and depression, wherein formula I is or a pharmaceutically acceptable salt or thereof, wherein Z is wherein Y is methylene; X is oxygen; n is 0; R<SUP>1 </SUP>and R<SUP>2 </SUP>are each hydrogen or halogen; and R<SUP>3 </SUP>and R<SUP>4 </SUP>together with the nitrogen atom to which they are attached form i) a saturated non-aromatic 3 to 7 membered monocyclic ring, said ring i) being unsubstituted or substituted or substituted with one or more (C<SUB>1</SUB>-C<SUB>4</SUB>)alkyl, (C<SUB>1</SUB>-C<SUB>4</SUB>)alkoxy(C<SUB>1</SUB>-C<SUB>4</SUB>)alkyl, or hydroxy groups. |